Advanced Search

Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use «Orlistat Eurogenerici».

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Orlistat Eurogenerici».

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
With no aRM-55/2015-1561 of February 26, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, no. 219, on renunciation of EG S.p.a. the marketing authorisation for the medicinal product in the boxes indicated below.
Medicine: ORLISTAT EUROGENERICI.
Packaging: A.I.C. # 041292018-' 60 mg hard capsules» 42 capsules in AL/PVC/PVDC;
A.I.C. # 041292020-' 60 mg capsules 60 capsules ' AL/PVC/PVDC;
A.I.C. # 041292032-' 60 mg hard capsules 84 capsules ' AL/PVC/PVDC;
A.I.C. # 041292044-' 60 mg hard capsules» 90 capsules in AL/PVC/PVDC;
A.I.C. # 041292057-' 60 mg hard capsules» 42 capsules in AL/PVC/PCTFE;
A.I.C. # 041292069-' 60 mg capsules 60 capsules ' AL/PVC/PCTFE;
A.I.C. # 041292071-' 60 mg hard capsules 84 capsules ' AL/PVC/PCTFE;
A.I.C. # 041292083-' 60 mg hard capsules» 90 capsules in AL/PVC/PCTFE;
A.I.C. # 041292095-' 60 mg hard capsules» 42 capsules in HDPE;
A.I.C. # 041292107-' 60 mg hard capsules 84 capsules ' in HDPE.
If the distribution channel were present stocks of medicine revoked, in the course of validity, the same will be disposed of not later than 180 days after the date of publication of this determination.